Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (5y) (2022 - 2025)

Analysis

Crinetics Pharmaceuticals (CRNX) Operating Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -581,504.00
Mar 31, 2024 -875,212.00
Sep 30, 2023 -1.56 Mn
Jun 30, 2023 -449,887.00
Mar 31, 2023 -54,067.00
Dec 31, 2022 -623,380.00
Sep 30, 2022 -911,684.00
Jun 30, 2022 -960,776.00